These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


195 related items for PubMed ID: 2668502

  • 1. Antihypertensive mechanism of captopril in renal hypertensive rats: studies with a nonpeptide angiotensin II receptor antagonist and an angiotensin II monoclonal antibody.
    Wong PC, Price WA, Reilly TM, Duncia JV, Timmermans PB.
    J Pharmacol Exp Ther; 1989 Aug; 250(2):515-22. PubMed ID: 2668502
    [Abstract] [Full Text] [Related]

  • 2. Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent.
    Wong PC, Price WA, Chiu AT, Duncia JV, Carini DJ, Wexler RR, Johnson AL, Timmermans PB.
    J Pharmacol Exp Ther; 1990 Feb; 252(2):726-32. PubMed ID: 2179532
    [Abstract] [Full Text] [Related]

  • 3. Characterization of the functional antagonism and antihypertensive activity displayed by a monoclonal antibody to angiotensin II.
    Reilly TM, Wong PC, Price WA, Timmermans PB.
    J Pharmacol Exp Ther; 1988 Jan; 244(1):160-5. PubMed ID: 3275771
    [Abstract] [Full Text] [Related]

  • 4. The antihypertensive effect of the angiotensin II receptor antagonist DuP 753 may not be due solely to angiotensin II receptor antagonism.
    Ohlstein EH, Gellai M, Brooks DP, Vickery L, Jugus J, Sulpizio A, Ruffolo RR, Weinstock J, Edwards RM.
    J Pharmacol Exp Ther; 1992 Aug; 262(2):595-601. PubMed ID: 1501114
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent.
    Wong PC, Price WA, Chiu AT, Duncia JV, Carini DJ, Wexler RR, Johnson AL, Timmermans PB.
    J Pharmacol Exp Ther; 1990 Feb; 252(2):719-25. PubMed ID: 2179531
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2).
    Wong PC, Hart SD, Zaspel AM, Chiu AT, Ardecky RJ, Smith RD, Timmermans PB.
    J Pharmacol Exp Ther; 1990 Nov; 255(2):584-92. PubMed ID: 2243344
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, SK&F 108566.
    Edwards RM, Aiyar N, Ohlstein EH, Weidley EF, Griffin E, Ezekiel M, Keenan RM, Ruffolo RR, Weinstock J.
    J Pharmacol Exp Ther; 1992 Jan; 260(1):175-81. PubMed ID: 1309870
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological evaluation in conscious dogs of factors involved in the renal vasodilator effect of captopril.
    Wong PC, Zimmerman BG, Kraft E, Kounenis G, Friedman P.
    J Pharmacol Exp Ther; 1981 Dec; 219(3):646-50. PubMed ID: 7028950
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
    Bing RF, Russell GI, Swales JD, Thurston H.
    J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.